Cardiovascular Diabetology (CD) is a scholarly journal dedicated to publishing research in the field of Medicine. BioMed Central is the publisher of this esteemed journal. and its abbreviated form is Cardiovasc Diabetol.
Cardiovascular Diabetology is an open access, peer-reviewed, online journal that considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome; this includes genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research. Cardiovascular Diabetology aims to provide an address for all types of scientific communications related to the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome. The impressive correlation between coronary artery disease and alterations in glucose metabolism has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents.
Journal title | Cardiovascular Diabetology (CD) |
Abbreviation | Cardiovasc Diabetol |
Online ISSN | 1475-2840 |
Publisher Name | BioMed Central |
Editor-in-chief | Enrique Fisman |
Subject Category | Medicine |
Cardiovascular Diabetology Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Cardiovascular Diabetology Journal is Cardiovasc Diabetol.
The Ranking of Cardiovascular Diabetology in 2023 is 996. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Impact Factor of Cardiovascular Diabetology in 2023 is 9.6. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The SCImago of Cardiovascular Diabetology in 2023 is 2.361. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The H-Index of Cardiovascular Diabetology in 2023 is 96. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Quartile of Cardiovascular Diabetology is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Cardiovascular Diabetology is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
✅ | ✅ | ✅ | ✅ | ✅ | ✅ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Cardiovasc Diabetol |
Access type | Open Access |
Impact Factor | 9.6 |
SJR | 2.361 |
SNIP | 2.054 |
Ranking | 996 |
CiteScore | 12.3 |
H-Index | 96 |
The Editor-in-chief of Cardiovascular Diabetology is Enrique Fisman
Cardiovascular Diabetology Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of Cardiovascular Diabetology is 3090 EUR, 3690 USD, 2790 GBP
Cardiovascular Diabetology Call for paper : Cardiovascular Diabetology invites original research contributions for consideration of publication in Cardiovascular Diabetology journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Cardiovascular Diabetology involves the following steps:
Yes, the Cardiovascular Diabetology journal is indexed in PubMed.
Yes, the Cardiovascular Diabetology journal is indexed in Scopus.
Yes, the Cardiovascular Diabetology journal is indexed in UGC.
No, the Cardiovascular Diabetology journal is not indexed in Index copernicus.
No, Cardiovascular Diabetology journal is not a predatory journal.
The Impact Factor of the Cardiovascular Diabetology is 9.6.
The Ranking of the Cardiovascular Diabetology is 996.
Yes the Cardiovascular Diabetology (CD) journal is a peer-reviewed journal.
Yes the Cardiovascular Diabetology journal is a peer-reviewed journal and good to publish your paper.
Cardiovascular Diabetology (CD) is a scholarly journal dedicated to publishing research in the field of Medicine. BioMed Central is the publisher of this esteemed journal.
Yes, Cardiovascular Diabetology is a open access journal.